We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

WHO Says Oxford’s Vaccine Is Safe and Likely to Be Efficacious in Older Adults

News   Feb 10, 2021 | Original story from the University of Oxford

 
WHO Says Oxford’s Vaccine Is Safe and Likely to Be Efficacious in Older Adults
 
 
Advertisement
 

RELATED ARTICLES

Industrial-Scale Farming May Be Perpetuating Spread of Antibiotic Resistant Staphs Through Pigs and People

News

According to a study, multidrug-resistant Staphylococcus aureus strains are spreading between pigs, farmworkers, their families and community residents, which could represent an emerging public health threat.

READ MORE

Chronic Skin Inflammation Molecular Mechanisms Identified

News

Researchers have identified new molecular mechanisms as causes for chronic skin inflammation like in atopic dermatitis (AD or neurodermatitis) and psoriasis that could provide suitable starting points for new therapies.

READ MORE

NIH Closes Enrolment for Two Sub-Studies in ACTIV-3 Trial

News

The ACTIV-3 clinical trial, which is evaluating the safety and efficacy of investigational therapeutics for COVID-19 in hospitalized patients, has closed enrolment in two sub-studies. The first sub-study was examining the investigational monoclonal antibody therapy VIR-7831 and the second was evaluating a combined monoclonal antibody therapy containing BRII-196 and BRII-198.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE